ASAVIE TECHNOLOGIES LIMITED – Trademark Portfolio
Entity Type: 11
ASAVIE TECHNOLOGIES LIMITED holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ACCESSMYLAN, BRANCH OF ONE, and ASAVIE SD EDGE. The owner is based in Dublin 4.
Fleming Court, Fleming Place
Dublin 4 , IE
Showing of trademarks Trademarks
Trademark Classifications
ASAVIE TECHNOLOGIES LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ASAVIE TECHNOLOGIES LIMITED have?
ASAVIE TECHNOLOGIES LIMITED has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.
What trademark classes does ASAVIE TECHNOLOGIES LIMITED file in?
ASAVIE TECHNOLOGIES LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ASAVIE TECHNOLOGIES LIMITED's most well-known trademarks?
ASAVIE TECHNOLOGIES LIMITED's registered trademark portfolio includes well-known marks such as ACCESSMYLAN, BRANCH OF ONE, and ASAVIE SD EDGE. These are among 3 currently registered trademarks in the portfolio.
What is ASAVIE TECHNOLOGIES LIMITED's trademark registration success rate?
ASAVIE TECHNOLOGIES LIMITED has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.